Triaminic-D Multi-Symptom Cold Interactions
There are 552 drugs known to interact with Triaminic-D Multi-Symptom Cold (chlorpheniramine/dextromethorphan/pseudoephedrine), along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 86 are major, 458 are moderate, and 8 are minor.
- View all 552 medications that may interact with Triaminic-D Multi-Symptom Cold
- View Triaminic-D Multi-Symptom Cold alcohol/food interactions (2)
- View Triaminic-D Multi-Symptom Cold disease interactions (10)
Most frequently checked interactions
View interaction reports for Triaminic-D Multi-Symptom Cold (chlorpheniramine / dextromethorphan / pseudoephedrine) and the medicines listed below.
- bacitracin / polymyxin b ophthalmic
- Gentak (gentamicin ophthalmic)
- Patanol (olopatadine ophthalmic)
- polymyxin b/trimethoprim ophthalmic
- Pred Forte (prednisolone ophthalmic)
- sulfacetamide sodium ophthalmic
- Zymar (gatifloxacin ophthalmic)
Triaminic-D Multi-Symptom Cold alcohol/food interactions
There are 2 alcohol/food interactions with Triaminic-D Multi-Symptom Cold (chlorpheniramine / dextromethorphan / pseudoephedrine).
Triaminic-D Multi-Symptom Cold disease interactions
There are 10 disease interactions with Triaminic-D Multi-Symptom Cold (chlorpheniramine / dextromethorphan / pseudoephedrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
More about Triaminic-D Multi-Symptom Cold (chlorpheniramine / dextromethorphan / pseudoephedrine)
- Triaminic-D Multi-Symptom Cold consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.